#Canada #Toronto #Real-World Data #Xtalks #AI in Pharma

Embracing AI in Real-World Data Adoption

As the healthcare landscape evolves, real-world data (RWD) and real-world evidence (RWE) have become pivotal in pharmaceutical research and development. Upcoming on March 3, 2026, at 1 PM EST, Xtalks is set to host a groundbreaking webinar that delves into the transformative role of artificial intelligence (AI) in driving the effective adoption of RWD. The event aims to shed light on the integration of data from real-world sources including electronic health records (EHR), claims, and imaging, providing valuable insights into industry practices and innovations.

The Importance of RWD and RWE in Pharma

Today, life's sciences organizations increasingly depend on RWD and RWE to bolster evidence generation, heighten operational efficiency, and promote patient safety. These data sources offer a comprehensive view of patient experiences and treatment outcomes, ultimately guiding clinical decision-making throughout the drug development lifecycle.

The webinar will present recent findings, particularly from the Tufts Center for the Study of Drug Development, which highlights how RWD and RWE are currently being embraced in the pharmaceutical sector and identifies areas ripe for enhanced impact and engagement.

Key Highlights of the Webinar

Attendees of the Xtalks webinar will benefit from discussions featuring notable experts such as Ken Getz, Executive Director at Tufts CSDD, Mary Jo Lamberti, PhD, and Aracelis Torres, PhD, MPH from Verana Health. The conversation will cover:

• - AI’s Impact: A comprehensive understanding of how AI facilitates the curation and analysis of RWD to improve the drug development workflow.
• - Diverse Use Cases: Exploration of RWD/RWE applications beyond clinical trials, encompassing areas such as patient recruitment and pharmacovigilance.
• - Current Adoption Trends: Analyzing the existing landscape of RWD/RWE application, its challenges, and potential ROI for stakeholders in the health sector.
• - Innovative Data Sources: The discussion will also touch on emerging data sources outside traditional EHRs that can be leveraged to enrich RWD curation.

Why You Should Attend

This webinar presents a unique opportunity for industry professionals to gain actionable knowledge on transforming RWD into high-quality, evidence-driven decisions that can revolutionize pharmaceutical research and development. With AI at the helm, the potential to enhance study designs, optimize site selection, and support patient recruitment is being realized in real-time, driving the industry forward.

Don’t miss out on the chance to learn from industry leaders on how you can leverage RWD and AI to foster innovation and advance patient care. To reserve your spot and gather more information, visit the Xtalks site.

About Xtalks

Xtalks serves as a vital resource for professionals across the pharmaceutical, biotech, and healthcare sectors. By providing essential knowledge and resources, it empowers professionals to navigate a rapidly changing industry landscape. With a blend of webinars, articles, and podcasts, Xtalks continues to elevate industry standards and foster collaboration among peers.

Join us at this insightful event as we collectively explore the future of RWD and RWE powered by AI.